| Sorrento Therpt (SRNE) | |||
|---|---|---|---|
| 9.28 -0.36 (-3.73%) | 01-25 16:00 | ||
| Open: | 9.51 | Pre. Close: | 9.64 |
| High: | 9.7 | Low: | 8.7644 |
| Volume: | 20,553,839 | Market Cap: | 2,540M |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 9.711 - 9.79 | 9.79 - 9.843 |
| Low: | 8.608 - 8.689 | 8.689 - 8.743 |
| Close: | 9.169 - 9.3 | 9.3 - 9.389 |
| Stock Technical Analysis | |
|---|---|
| Overall: |   |
| Target: | Six months: 12.59 One year: 14.71 |
| Support: | Support1: 8.18 Support2: 6.58 |
| Resistance: | Resistance1: 10.78 Resistance2: 12.59 |
| Pivot: | 8.25  |
| Moving Averages: | MA(5): 9.67 MA(20): 8.00 MA(100): 8.15 MA(250): 6.29 |
| MACD: | MACD(12,26): 0.57 Signal(12,26,9): 0.33 |
| %K %D: | %K(14,3): 72.70 %D(3): 76.11 |
| RSI: | RSI(14): 60.88 |
| 52-Week: | High: 19.39 Low: 1.55 Change(%): 129.1 |
| Average Vol(K): | 3-Month: 1552980 10-Days: 2151102 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.SRNE has closed below upper band by 28.0%. Bollinger Bands are 34.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Growth | |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. | |
| Profitability | |
| Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs. | |
| Solvency | |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. | |
| Efficiency |  |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: NASDAQ Capital Market | |
| Sector: Healthcare | |
| Industry: Biotechnology | |
| Shares Out. (M) | 273.70 |
| Shares Float (M) | 198.53 |
| % Held by Insiders | 15.71 |
| % Held by Institutions | 27.97 |
| Shares Short (K) | 68980 |
| Shares Short Prior Month (K) | 75390 |
| Stock Financials | |
|---|---|
| EPS | -1.500 |
| Book Value (p.s.) | 0.810 |
| Profit Margin | |
| Operating Margin | -428.52 |
| Return on Assets (ttm) | -19.1 |
| Return on Equity (ttm) | -409.0 |
| Qtrly Rev. Growth | 103.4 |
| Gross Profit (p.s.) | -0.320 |
| Sales Per Share | 0.152 |
| EBITDA (p.s.) | -0.608 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | -154.69 |
| Levered Free Cash Flow (M) | -141.04 |
| Stock Valuation | |
|---|---|
| PE Ratio | -6.19 |
| PEG Ratio | |
| Price to Book value | 11.46 |
| Price to Sales | 61.17 |
| Price to Cash Flow | -16.42 |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
